Skip to content

The Archive · A Source

Singapore HSA Accepts NDA for Equecabtagene Autoleucel

PR Newswire 2025 www.prnewswire.com/news-releases/iaso-bio-announces-acceptance-of-new-drug-application-for-equecabtagene-autoleucel-fucaso-by-the-singapore-health-sciences-authority-hsa-302363236.html